{"id":"https://openalex.org/W2129016258","doi":"https://doi.org/10.1086/510860","title":"Pharmacokinetics of Antimony in Children Treated for Leishmaniasis with Meglumine Antimoniate","display_name":"Pharmacokinetics of Antimony in Children Treated for Leishmaniasis with Meglumine Antimoniate","publication_year":2007,"publication_date":"2007-01-23","ids":{"openalex":"https://openalex.org/W2129016258","doi":"https://doi.org/10.1086/510860","mag":"2129016258","pmid":"https://pubmed.ncbi.nlm.nih.gov/17230422"},"language":"en","primary_location":{"id":"doi:10.1086/510860","doi":"https://doi.org/10.1086/510860","is_oa":false,"landing_page_url":"https://doi.org/10.1086/510860","pdf_url":null,"source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030288649","display_name":"Adriana R. Cruz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087692","display_name":"Centro Internacional de Entrenamiento e Investigaciones Medicas","ror":"https://ror.org/003s20294","country_code":"CO","type":"nonprofit","lineage":["https://openalex.org/I4210087692"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Adriana Cruz","raw_affiliation_strings":["Centro Internacional de Entrenamiento e Investigaciones Medicas, Cali, AA 5390, Colombia","Centro Internacional de Entrenamiento e Investigaciones M\u00e9dicas, Cali, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Internacional de Entrenamiento e Investigaciones Medicas, Cali, AA 5390, Colombia","institution_ids":["https://openalex.org/I4210087692"]},{"raw_affiliation_string":"Centro Internacional de Entrenamiento e Investigaciones M\u00e9dicas, Cali, Colombia","institution_ids":["https://openalex.org/I4210087692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023959197","display_name":"Petrie M. Rainey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Petrie\u00a0M. Rainey","raw_affiliation_strings":["Department of Laboratory Medicine, University of Washington, Seattle"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, University of Washington, Seattle","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035489154","display_name":"Barbara L. Herwaldt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara\u00a0L. Herwaldt","raw_affiliation_strings":["Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia","institution_ids":["https://openalex.org/I1289490764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059392074","display_name":"Grazia Stagni","orcid":"https://orcid.org/0000-0002-5991-2552","observed_orcids":["https://orcid.org/0000-0002-5991-2552"]},"institutions":[{"id":"https://openalex.org/I138873065","display_name":"Long Island University","ror":"https://ror.org/0324fzh77","country_code":"US","type":"education","lineage":["https://openalex.org/I138873065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grazia Stagni","raw_affiliation_strings":["Arnold & Marie Schwartz College of Pharmacy, Long Island University, Brooklyn, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arnold & Marie Schwartz College of Pharmacy, Long Island University, Brooklyn, New York","institution_ids":["https://openalex.org/I138873065"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050887248","display_name":"Ricardo Pal\u00e1cios","orcid":"https://orcid.org/0000-0002-1410-8579","observed_orcids":["https://orcid.org/0000-0002-1410-8579"]},"institutions":[{"id":"https://openalex.org/I4210087692","display_name":"Centro Internacional de Entrenamiento e Investigaciones Medicas","ror":"https://ror.org/003s20294","country_code":"CO","type":"nonprofit","lineage":["https://openalex.org/I4210087692"]},{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR","CO"],"is_corresponding":false,"raw_author_name":"Ricardo Palacios","raw_affiliation_strings":["Centro Internacional de Entrenamiento e Investigaciones M\u00e9dicas, Cali, Colombia","Division of Infectious Diseases, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Internacional de Entrenamiento e Investigaciones M\u00e9dicas, Cali, Colombia","institution_ids":["https://openalex.org/I4210087692"]},{"raw_affiliation_string":"Division of Infectious Diseases, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I88273585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052685630","display_name":"Rodolfo Trujillo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087692","display_name":"Centro Internacional de Entrenamiento e Investigaciones Medicas","ror":"https://ror.org/003s20294","country_code":"CO","type":"nonprofit","lineage":["https://openalex.org/I4210087692"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Rodolfo Trujillo","raw_affiliation_strings":["Centro Internacional de Entrenamiento e Investigaciones M\u00e9dicas, Cali, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Internacional de Entrenamiento e Investigaciones M\u00e9dicas, Cali, Colombia","institution_ids":["https://openalex.org/I4210087692"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002136191","display_name":"Nancy Gore Saravia","orcid":"https://orcid.org/0000-0002-2440-9658","observed_orcids":["https://orcid.org/0000-0002-2440-9658"]},"institutions":[{"id":"https://openalex.org/I4210087692","display_name":"Centro Internacional de Entrenamiento e Investigaciones Medicas","ror":"https://ror.org/003s20294","country_code":"CO","type":"nonprofit","lineage":["https://openalex.org/I4210087692"]}],"countries":["CO"],"is_corresponding":true,"raw_author_name":"Nancy\u00a0G. Saravia","raw_affiliation_strings":["Centro Internacional de Entrenamiento e Investigaciones M\u00e9dicas, Cali, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Internacional de Entrenamiento e Investigaciones M\u00e9dicas, Cali, Colombia","institution_ids":["https://openalex.org/I4210087692"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5002136191"],"corresponding_institution_ids":["https://openalex.org/I4210087692"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":2.7441,"has_fulltext":false,"cited_by_count":81,"citation_normalized_percentile":{"value":0.8978967,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"195","issue":"4","first_page":"602","last_page":"608"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.9077000021934509,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.9077000021934509,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.08900000154972076,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/meglumine-antimoniate","display_name":"meglumine antimoniate","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cutaneous-leishmaniasis","display_name":"cutaneous leishmaniasis","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pediatric-drug-exposure","display_name":"pediatric drug exposure","score":0.6919999718666077},{"id":"https://openalex.org/keywords/pentavalent-antimonials","display_name":"pentavalent antimonials","score":0.7540000081062317}],"concepts":[{"id":"https://openalex.org/C2780423678","wikidata":"https://www.wikidata.org/wiki/Q2757969","display_name":"Meglumine antimoniate","level":4,"score":0.9916212558746338},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7179024815559387},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5663986802101135},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4683857262134552},{"id":"https://openalex.org/C541565711","wikidata":"https://www.wikidata.org/wiki/Q1099","display_name":"Antimony","level":2,"score":0.4266323149204254},{"id":"https://openalex.org/C2776555147","wikidata":"https://www.wikidata.org/wiki/Q331283","display_name":"Leishmaniasis","level":2,"score":0.4034881293773651},{"id":"https://openalex.org/C2778702967","wikidata":"https://www.wikidata.org/wiki/Q2590966","display_name":"Cutaneous leishmaniasis","level":3,"score":0.27104511857032776},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1955532431602478},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11867830157279968},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077485","descriptor_name":"Meglumine Antimoniate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000965","descriptor_name":"Antimony","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008536","descriptor_name":"Meglumine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008536","descriptor_name":"Meglumine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010949","descriptor_name":"Plasma","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016773","descriptor_name":"Leishmaniasis, Cutaneous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016773","descriptor_name":"Leishmaniasis, Cutaneous","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1086/510860","doi":"https://doi.org/10.1086/510860","is_oa":false,"landing_page_url":"https://doi.org/10.1086/510860","pdf_url":null,"source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:17230422","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17230422","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of infectious diseases","raw_type":"Comparative Study"},{"id":"pmh:oai:repositorio.unifesp.br:11600/29512","doi":null,"is_oa":false,"landing_page_url":"http://repositorio.unifesp.br/handle/11600/29512","pdf_url":null,"source":{"id":"https://openalex.org/S4377196380","display_name":"UNIFESP Institutional Repository (Universidade Federal de S\u00e3o Paulo)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I88273585","host_organization_name":"Universidade Federal de S\u00e3o Paulo","host_organization_lineage":["https://openalex.org/I88273585"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Artigo"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4911309173","display_name":"Clinical response and resistance to antimonial drugs in Leishmania.","funder_award_id":"059056","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W54929421","https://openalex.org/W1971247424","https://openalex.org/W1973826371","https://openalex.org/W1992034033","https://openalex.org/W2009610464","https://openalex.org/W2026547035","https://openalex.org/W2047634773","https://openalex.org/W2074850559","https://openalex.org/W2081253388","https://openalex.org/W2093199671","https://openalex.org/W2106399556","https://openalex.org/W2122527560","https://openalex.org/W2123479775","https://openalex.org/W2136118868","https://openalex.org/W2137175522","https://openalex.org/W2140296238","https://openalex.org/W2144756920","https://openalex.org/W2153690513","https://openalex.org/W2293035635","https://openalex.org/W2398535685","https://openalex.org/W2464000837"],"related_works":["https://openalex.org/W2093199671","https://openalex.org/W2921832794","https://openalex.org/W2884921577","https://openalex.org/W4402349585","https://openalex.org/W1979335818","https://openalex.org/W7042972084","https://openalex.org/W2045677833","https://openalex.org/W7097469681","https://openalex.org/W1992938086","https://openalex.org/W2013612960"],"abstract_inverted_index":{"BACKGROUND:":[0],"In":[1],"some":[2],"settings,":[3],"the":[4,35,62,75,100,103,164,172,191],"response":[5],"to":[6,166,175],"pentavalent":[7],"antimonial":[8],"therapy":[9],"for":[10,72,85],"leishmaniasis":[11,53],"may":[12],"be":[13],"lower":[14,121,138,183],"in":[15,18,40,108,161,184,187],"children":[16,46,66,79,162,185],"than":[17,186],"adults.":[19],"We":[20,33],"hypothesized":[21],"that":[22],"there":[23],"are":[24],"age-dependent":[25],"pharmacokinetic":[26],"differences":[27],"of":[28,37,45,65,78,195],"potential":[29],"clinical":[30],"relevance.":[31],"METHODS:":[32],"compared":[34,132],"pharmacokinetics":[36],"antimony":[38,204],"(Sb)":[39],"adults":[41,188],"and":[42,61,88,146,171],"2":[43],"groups":[44],"3-6":[47],"years":[48],"old":[49],"who":[50,114],"had":[51,118],"cutaneous":[52],"treated":[54,189],"with":[55,133,190],"intramuscular":[56],"meglumine":[57,196],"antimoniate.":[58],"Adults":[59],"(n=9)":[60,67],"first":[63],"group":[64,77],"received":[68,81,115],"20":[69,73,82,116],"mg":[70,83,90,129,168],"Sb/kg/day":[71],"days;":[74],"second":[76],"(n=6)":[80],"Sb/kg":[84,91],"19":[86],"days":[87],"30":[89,158],"on":[92],"day":[93],"20.":[94],"Drug":[95,179],"exposure":[96,180],"was":[97],"assessed":[98],"by":[99],"area":[101],"under":[102],"24-h":[104],"time-concentration":[105],"curve":[106],"(AUC(0-24))":[107],"plasma.":[109],"RESULTS:":[110],"Children":[111],"(vs.":[112],"adults)":[113],"mg/kg":[117,159],"a":[119,136,147,202],"42%":[120],"AUC(0-24)":[122,165],"(mean":[123],"+/-":[124],"SE,":[125],"111+/-7":[126],"vs.":[127,142,153],"190+/-10":[128],"x":[130,169],"h/L,":[131],"adults;":[134],"P<.001),":[135],"16%":[137],"peak":[139,173],"concentration":[140,174],"(32.7+/-0.9":[141],"38.8+/-2.1":[143],"mg/L;":[144],"P=.04),":[145],"75%":[148],"higher":[149,203],"weight-adjusted":[150,193],"clearance":[151,205],"(0.185+/-0.013":[152],"0.106+/-0.006":[154],"L/h/kg;":[155],"P<.001).":[156],"The":[157],"dose":[160],"increased":[163],"164+/-10":[167],"h/L":[170],"43.8+/-2.3":[176],"mg/L.":[177],"CONCLUSIONS:":[178],"is":[181],"significantly":[182],"same":[192],"regimen":[194],"antimoniate,":[197],"which":[198],"primarily":[199],"stems":[200],"from":[201],"rate.":[206]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}